Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
3.060
-0.160 (-4.97%)
Aug 24, 2026, 10:55 AM EDT - Market open
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $1.21 million as of August 24, 2026. Its market cap has decreased by -18.89% in one year.
Market Cap
1.21M
Enterprise Value
2.14M
1-Year Change
-18.89%
Ranking
Category
Stock Price
$3.06
ChartMarket Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $5.41M to $1.21M, a decrease of -77.62%. That is a compound annual growth rate of -12.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 1.21M | -50.94% |
| Dec 31, 2025 | 2.47M | -13.44% |
| Dec 31, 2024 | 2.85M | 10.12% |
| Dec 29, 2023 | 2.59M | -74.89% |
| Dec 30, 2022 | 10.32M | -76.24% |
| Dec 31, 2021 | 43.42M | 34.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HCW Biologics | 2.60M |
| Clearmind Medicine | 2.58M |
| Onconetix | 2.57M |
| Virax Biolabs Group | 2.54M |
| Propanc Biopharma | 2.46M |
| Oragenics | 2.37M |
| CDT Equity | 2.25M |
| Silexion Therapeutics | 2.19M |